首页> 外文期刊>Expert opinion on drug discovery >X-ray crystallography over the past decade for novel drug discovery - where are we heading next?
【24h】

X-ray crystallography over the past decade for novel drug discovery - where are we heading next?

机译:过去十年中用于新型药物发现的X射线晶体学-我们下一步将走向何方?

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Macromolecular X-ray crystallography has been the primary methodology for determining the three-dimensional structures of proteins, nucleic acids and viruses. Structural information has paved the way for structure-guided drug discovery and laid the foundations for structural bioinformatics. However, X-ray crystallography still has a few fundamental limitations, some of which may be overcome and complemented using emerging methods and technologies in other areas of structural biology.
机译:简介:高分子X射线晶体学一直是确定蛋白质,核酸和病毒的三维结构的主要方法。结构信息为结构指导的药物发现铺平了道路,并为结构生物信息学奠定了基础。但是,X射线晶体学仍然具有一些基本的局限性,其中一些局限性可以使用结构生物学其他领域中的新兴方法和技术加以克服和补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号